|
|
|
|
| LEADER |
06941cam a2200769Ii 4500 |
| 001 |
992119228 |
| 003 |
OCoLC |
| 005 |
20180526095104.1 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170628s2017 ne o 001 0 eng d |
| 019 |
|
|
|a 992265755
|a 992734972
|
| 020 |
|
|
|a 9780323527347
|q (electronic bk.)
|
| 020 |
|
|
|a 0323527345
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323527330
|
| 020 |
|
|
|z 0323527337
|
| 024 |
0 |
|
|a 40027455223
|
| 035 |
|
|
|a (OCoLC)992119228
|z (OCoLC)992265755
|z (OCoLC)992734972
|
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d IDEBK
|d EBLCP
|d YDX
|d UIU
|d OPELS
|d GZM
|d MERER
|d UAB
|d STF
|d OCLCF
|d OCLCQ
|d ESU
|d UPM
|d OCLCQ
|d U3G
|d D6H
|d COS
|d COF
|
| 049 |
|
|
|a COM6
|
| 050 |
|
4 |
|a RM267
|
| 066 |
|
|
|c (S
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.329
|2 23
|
| 245 |
0 |
0 |
|a Antimicrobial nanoarchitectonics :
|b from synthesis to applications /
|c edited by Alexandru Mihai Grumezescu.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c [2017]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 505 |
0 |
|
|a Cover; Title Page; Copyright Page; Contents; List of Contributors; Foreword; Preface; Chapter 1 - New Trends in the Antimicrobial Agents Delivery Using Nanoparticles; 1 - Introduction; 2 - Nanoparticles for drug-delivery systems; 3 - Polymeric carriers used to prepare nanoparticles as drug carriers; 3.1 - Natural Polymers; 3.1.1 - Alginates; 3.1.2 - Chitosan; 3.1.3 - Gelatin; 3.2 - Semisynthetic Polymers; 3.3 - Synthetic Biodegradable Polymers; 3.3.1 - Poly(esters); 3.3.2 - Poly(anhydrides); 3.3.3 - Poly-[epsilon]-Caprolactones; 3.3.4 - Poly(orthoesters)
|
| 505 |
8 |
|
|a 5.1.2.1 - Aluminium oxide nanoparticles5.1.2.2 - Magnesium oxide nanoparticles; 5.1.2.3 - Copper oxide nanoparticles; 5.1.2.4 - Zinc oxide nanoparticles; 5.1.2.5 - Titanium dioxide nanoparticles; 5.1.2.6 - Nitric oxide nanoparticles; 5.1.2.7 - Iron oxide; 5.2 - Organic Nanoparticles; 5.2.1 - Poly-[epsilon]-lysine; 5.2.2 - Triclosan; 5.2.3 - Quaternary Ammonium Compounds; 5.2.4 - Polyethyleneimine; 5.2.5 - Cationic Quaternary Polyelectrolytes; 5.2.6 - N-Halamine compounds; 5.2.7 - Polysiloxanes; 5.2.8 - Benzoic Acid, Phenol, and P-Hydroxy Benzoate Esters; 5.2.9 - Benzaldehyde.
|
| 505 |
8 |
|
|a 4 -- Recent trends in nanoparticulate drug-delivery systems4.1 -- Biological Transport of Nanoparticles; 4.2 -- Ideal Properties of Nanoparticle Delivery Systems; 4.3 -- Types of Nanoparticulate Drug Delivery System; 4.3.1 -- Polymeric Micelles; 4.3.2 -- Microemulsion; 4.3.3 -- Liposomes; 4.3.4 -- Solid Lipid Nanoparticles; 4.3.5 -- Lipid Nanocapsules; 4.3.6 -- Dendrimers; 4.3.7 -- Chitosan-Based Nanoparticulate; 5 -- Application of nanoparticles/diverse and emerging trends in nanoparticles applications; 6 -- Concluding remarks and future prospects; References.
|
| 505 |
8 |
|
|a Chapter 2 -- Nanostructures as Antimicrobial Therapeutics1 -- Introduction; 2 -- Nanoparticles as antimicrobial agents; 2.1 -- What Are Nanostructures?; 2.2 -- Distinctive Properties of Nanoparticles; 2.2.1 -- Appropriate Size; 2.2.2 -- Surface Chemistry (Functionalizable Structure); 2.2.3 -- Chemical Stability; 2.2.4 -- High Surface Area to Mass Ratio; 2.2.5 -- High Reactivity; 2.2.6 -- Biosafety and Biocompatibility; 3 -- Mode of action of nanoparticles; 3.1 -- Cell Membrane Damage; 3.2 -- Release of Toxic Ions; 3.3 -- Interruption of Electron Transport, Protein Oxidation, and Membrane Collapse.
|
| 505 |
8 |
|
|a 3.4 -- Generation of Reactive Oxygen Species (ROS)3.5 -- Photothermal Damage; 4 -- Nanoparticles use in antimicrobial therapy; 4.1 -- As Conjugates to Enhance Activity of Already Existing Antibiotics; 4.2 -- As Antimicrobial Agents; 4.3 -- As Encapsulating Agents for Efficient Drug Delivery; 4.4 -- For Surface Coating in Medical Devices; 4.5 -- As Antimicrobial Nanovaccines; 4.5.1 -- Nanoparticles for Vaccine Delivery; 4.5.2 -- Nanoadjuvants; 5 -- Types of nanoparticles; 5.1 -- Inorganic; 5.1.1 -- Metals; 5.1.1.1 -- Silver nanoparticles; 5.1.1.2 -- Gold nanoparticles; 5.1.2 -- Metal Oxide Nanoparticles.
|
| 505 |
8 |
|
|a 5.2.10 -- Quaternary Phosphonium or Sulfonium Groups.
|
| 650 |
|
0 |
|a Anti-infective agents.
|
| 650 |
|
0 |
|a Nanostructured materials.
|
| 650 |
|
7 |
|a MEDICAL / Pharmacology.
|2 bisacsh.
|
| 650 |
|
7 |
|a Anti-infective agents.
|2 fast.
|
| 650 |
|
7 |
|a Nanostructured materials.
|2 fast.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Grumezescu, Alexandru Mihai,
|e editor.
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|c Original
|z 9780323527330
|z 0323527337
|w (OCoLC)960845576.
|
| 880 |
8 |
|
|6 505-00
|a 5.1.2.1 - Aluminium oxide nanoparticles5.1.2.2 - Magnesium oxide nanoparticles; 5.1.2.3 - Copper oxide nanoparticles; 5.1.2.4 - Zinc oxide nanoparticles; 5.1.2.5 - Titanium dioxide nanoparticles; 5.1.2.6 - Nitric oxide nanoparticles; 5.1.2.7 - Iron oxide; 5.2 - Organic Nanoparticles; 5.2.1 - Poly-f-lysine; 5.2.2 - Triclosan; 5.2.3 - Quaternary Ammonium Compounds; 5.2.4 - Polyethyleneimine; 5.2.5 - Cationic Quaternary Polyelectrolytes; 5.2.6 - N-Halamine compounds; 5.2.7 - Polysiloxanes; 5.2.8 - Benzoic Acid, Phenol, and P-Hydroxy Benzoate Esters; 5.2.9 - Benzaldehyde.
|
| 880 |
0 |
|
|6 505-00
|a Cover; Title Page; Copyright Page; Contents; List of Contributors; Foreword; Preface; Chapter 1 - New Trends in the Antimicrobial Agents Delivery Using Nanoparticles; 1 - Introduction; 2 - Nanoparticles for drug-delivery systems; 3 - Polymeric carriers used to prepare nanoparticles as drug carriers; 3.1 - Natural Polymers; 3.1.1 - Alginates; 3.1.2 - Chitosan; 3.1.3 - Gelatin; 3.2 - Semisynthetic Polymers; 3.3 - Synthetic Biodegradable Polymers; 3.3.1 - Poly(esters); 3.3.2 - Poly(anhydrides); 3.3.3 - Poly-f-Caprolactones; 3.3.4 - Poly(orthoesters)
|
| 907 |
|
|
|a .b54595794
|b multi
|c -
|d 170731
|e 230110
|
| 998 |
|
|
|a cue
|a cu
|b 180626
|c m
|d z
|e -
|f eng
|g ne
|h 0
|i 2
|
| 948 |
|
|
|a MARCIVE Overnight, in 2023.01
|
| 948 |
|
|
|a MARCIVE Comp, 2019.12
|
| 948 |
|
|
|a MARCIVE Q2, 2018
|
| 948 |
|
|
|a MARCIVE Comp, 2018.05
|
| 948 |
|
|
|a MARCIVE August, 2017
|
| 948 |
|
|
|a MARCIVE extract Aug 5, 2017
|
| 994 |
|
|
|a 92
|b COM
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2023.01
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2019.12
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2018.08
|
| 995 |
0 |
0 |
|a OCLC offline update by CMU and loaded with m2btab.elec in 2018.06
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2018.06
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2017.09
|
| 995 |
|
|
|a Loaded with m2btab.elec in 2017.07
|
| 995 |
|
|
|a OCLC offline update by CMU
|
| 989 |
|
|
|d cueme
|e - -
|f - -
|g j
|h 0
|i 0
|j 188
|k 180626
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w Elsevier
|1 .i119684391
|u http://ezproxy.coloradomesa.edu/login?url=https://www.sciencedirect.com/science/book/9780323527330
|3 Elsevier
|z Click here for access
|